SAN FRANCISCO – Preparing for infectious disease outbreaks with potentially global impacts, both in the U.S. and abroad, must be a permanent and pivotal focus of the Centers for Disease Control and Prevention, CDC Director Dr. Robert Redfield said here in a conversation with IDSA President Dr. Paul Auwaerter and HIV Medicine Association Chair Dr. Melanie […]
The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight tuberculosis: the Global Accelerator to End TB, a business model to treat 40 million people by 2022 through performance-based investments. One of USAID’s initial efforts on this front is […]
HIV
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation For almost 35 years, HIV/AIDS has been a household word across the globe. […]
Tuberculosis
The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Estimate exceeds previous estimates by more than $20 billion Deaths from non-Ebola causes contributed to highest West Africa outbreak costs, authors say During the 2013 to […]